SHR-2042 is a selective agonist of the GLP-1 receptor.SHR-2042 improves glycemic control by activating the GLP-1 receptor, enhancing insulin secretion and inhibiting glucagon secretion. SHR-2042 combined with sodium N-(8-[2-hydroxybenzoyl] amino) capryla
Molecular Weight:
4458.97
Formula:
C205H314N48O63
Target:
GLP Receptor
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted